Effects of EpCAM overexpression on human breast cancer cell lines

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Gostner, Johanna M ^a   Fong, Dominic ^a,b   Wrulich, Oliver A ^c   Lehne, Florian ^a   Zitt, Marion ^a   Hermann, Martin ^d   Krobitsch, Sylvia ^e   Martowicz, Agnieszka ^a   Gastl, Guenther ^a,b   Spizzo, Gilbert ^a,b,f  

^a TYROLEAN CANCER RESEARCH INSTITUTE   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c Biocenter Innsbruck Fritz   (Austria)

^d KMT Laboratory   (Austria)

^e MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^f FRANZ TAPPEINER HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DOCETAXEL; EPITHELIAL CELL ADHESION MOLECULE; SECRETED FRIZZLED RELATED PROTEIN 1; TRANSCRIPTION FACTOR 7 LIKE 2; TRANSCRIPTOME; WNT PROTEIN; ANTINEOPLASTIC AGENT; CELL ADHESION MOLECULE; TACSTD1 PROTEIN, HUMAN; TAXOID; TUMOR ANTIGEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; BREAST TUMOR; CELL FRACTIONATION; CELL GROWTH; CELL MOTION; CONFOCAL MICROSCOPY; FEMALE; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEIN PROCESSING; TUMOR CELL LINE;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; BETA CATENIN; BREAST NEOPLASMS; CELL ADHESION MOLECULES; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICROSCOPY, CONFOCAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TAXOIDS; WNT PROTEINS;

EID: 79251556837     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-45     Document Type: Article

References (46)

1. Tandon AK, Clark GM, Chamness GC, McGuire WL. Association of the 323/A3 surface glycoprotein with tumor characteristics and behavior in human breast cancer. Cancer Res 1990, 50:3317-3321.
2. Gastl G, Spizzo G, Obrist P, Dunser M, Mikuz G. Ep-CAM overexpression in breast cancer as a predictor of survival. Lancet 2000, 356:1981-1982. 10.1016/S0140-6736(00)03312-2, 11130529.
3. Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, Maurer R, Metzger U, Von Castelberg B, Bart R, et al. High Ep-CAM Expression is Associated with Poor Prognosis in Node-positive Breast Cancer. Breast Cancer Res Treat 2004, 86:207-213. 10.1023/B:BREA.0000036787.59816.01, 15567937.
4. Schmidt M, Hasenclever D, Schaeffer M, Boehm D, Cotarelo C, Steiner E, Lebrecht A, Siggelkow W, Weikel W, Schiffer-Petry I, et al. Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer. Clin Cancer Res 2008, 14:5849-5855. 10.1158/1078-0432.CCR-08-0669, 18794096.
5. Spizzo G, Obrist P, Ensinger C, Theurl I, Dunser M, Ramoni A, Gunsilius E, Eibl G, Mikuz G, Gastl G. Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer. Int J Cancer 2002, 98:883-888. 10.1002/ijc.10270, 11948467.
6. Schmidt M, Scheulen ME, Dittrich C, Obrist P, Marschner N, Dirix L, Schmidt M, Ruttinger D, Schuler M, Reinhardt C, et al. An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer. Ann Oncol 2009,
7. Shen J, Zhu Z. Catumaxomab, a rat/murine hybrid trifunctional bispecific monoclonal antibody for the treatment of cancer. Curr Opin Mol Ther 2008, 10:273-284.
8. Balzar M, Prins FA, Bakker HA, Fleuren GJ, Warnaar SO, Litvinov SV. The structural analysis of adhesions mediated by Ep-CAM. Exp Cell Res 1999, 246:108-121. 10.1006/excr.1998.4263, 9882520.
9. Litvinov SV, Balzar M, Winter MJ, Bakker HA, Briaire-de Bruijn IH, Prins F, Fleuren GJ, Warnaar SO. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J Cell Biol 1997, 139:1337-1348. 10.1083/jcb.139.5.1337, 2140211, 9382878.
10. Munz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 2004, 23:5748-5758. 10.1038/sj.onc.1207610, 15195135.
11. Munz M, Zeidler R, Gires O. The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP. Cancer Lett 2005, 225:151-157. 10.1016/j.canlet.2004.11.048, 15922867.
12. Baeuerle PA, Gires O. EpCAM (CD326) finding its role in cancer. Br J Cancer 2007, 2360029, 17211480.
13. Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M, Kieu C, Papior P, Baeuerle PA, Munz M, et al. Nuclear signaling by tumour-associated antigen EpCAM. Nat Cell Biol 2009,
14. Spizzo G, Gastl G, Obrist P, Fong D, Haun M, Grunewald K, Parson W, Eichmann C, Millinger S, Fiegl H, et al. Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue. Cancer Lett 2007, 246:253-261. 10.1016/j.canlet.2006.03.002, 16624485.
15. Went PT, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G, Dirnhofer S. Frequent EpCam protein expression in human carcinomas. Hum Pathol 2004, 35:122-128. 10.1016/j.humpath.2003.08.026, 14745734.
16. Chaudry MA, Sales K, Ruf P, Lindhofer H, Winslet MC. EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges. Br J Cancer 2007, 96:1013-1019. 10.1038/sj.bjc.6603505, 2360124, 17325709.
17. Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA, Cole DJ, Gillanders WE. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 2004, 64:5818-5824. 10.1158/0008-5472.CAN-04-0754, 15313925.
18. Trzpis M, McLaughlin PM, de Leij LM, Harmsen MC. Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. Am J Pathol 2007, 171:386-395. 10.2353/ajpath.2007.070152, 1934518, 17600130.
19. Stulnig TM, Amberger A. Exposing contaminating phenol in nucleic acid preparations. Biotechniques 1994, 16:402-404.
20. Bieche I, Olivi M, Champeme MH, Vidaud D, Lidereau R, Vidaud M. Novel approach to quantitative polymerase chain reaction using real- time detection: application to the detection of gene amplification in breast cancer. Int J Cancer 1998, 78:661-666. 10.1002/(SICI)1097-0215(19981123)78:5<661::AID-IJC22>3.0.CO;2-I, 9808539.
21. Bieche I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R, Vidaud M. Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem 1999, 45:1148-1156.
22. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45. 10.1093/nar/29.9.e45, 55695, 11328886.
23. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002, 30:e36. 10.1093/nar/30.9.e36, 113859, 11972351.
24. Dzidic A, Mohr A, Meyer K, Bauer J, Meyer HH, Pfaffl MW. Effects of mycophenolic acid (MPA) treatment on expression of Fc receptor (FcRn) and polymeric immunoglobulin receptor (pIgR) mRNA in adult sheep tissues. Croat Med J 2004, 45:130-135.
25. Prang N, Preithner S, Brischwein K, Goster P, Woppel A, Muller J, Steiger C, Peters M, Baeuerle PA, da Silva AJ. Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines. Br J Cancer 2005, 92:342-349. 2361858, 15655555.
26. Zhang RD, Fidler IJ, Price JE. Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis 1991, 11:204-215.
27. Hackett AJ, Smith HS, Springer EL, Owens RB, Nelson-Rees WA, Riggs JL, Gardner MB. Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J Natl Cancer Inst 1977, 58:1795-1806.
28. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME, et al. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992, 150:534-544. 10.1002/jcp.1041500314, 1537883.
29. Zanna P, Trerotola M, Vacca G, Bonasera V, Palombo B, Guerra E, Rossi C, Lattanzio R, Piantelli M, Alberti S. Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression. Cancer 2007, 110:452-464. 10.1002/cncr.22785, 17559145.
30. Kolligs FT, Nieman MT, Winer I, Hu G, Van Mater D, Feng Y, Smith IM, Wu R, Zhai Y, Cho KR, et al. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. Cancer Cell 2002, 1:145-155. 10.1016/S1535-6108(02)00035-1, 12086873.
31. Balzar M, Bakker HA, Briaire-de-Bruijn IH, Fleuren GJ, Warnaar SO, Litvinov SV. Cytoplasmic tail regulates the intercellular adhesion function of the epithelial cell adhesion molecule. Mol Cell Biol 1998, 18:4833-4843. 109068, 9671492.
32. Shulewitz M, Soloviev I, Wu T, Koeppen H, Polakis P, Sakanaka C. Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer. Oncogene 2006, 25:4361-4369. 10.1038/sj.onc.1209470, 16532032.
33. Hoppler S, Kavanagh CL. Wnt signaling: variety at the core. J Cell Sci 2007, 120:385-393. 10.1242/jcs.03363, 17251379.
34. Uren A, Reichsman F, Anest V, Taylor WG, Muraiso K, Bottaro DP, Cumberledge S, Rubin JS. Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol Chem 2000, 275:4374-4382. 10.1074/jbc.275.6.4374, 10660608.
35. Ugolini F, Charafe-Jauffret E, Bardou VJ, Geneix J, Adelaide J, Labat-Moleur F, Penault-Llorca F, Longy M, Jacquemier J, Birnbaum D, et al. WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene 2001, 20:5810-5817. 10.1038/sj.onc.1204706, 11593386.
36. Wong SC, Lo SF, Lee KC, Yam JW, Chan JK, Wendy Hsiao WL. Expression of frizzled-related protein and Wnt-signaling molecules in invasive human breast tumours. J Pathol 2002, 196:145-153. 10.1002/path.1035, 11793365.
37. Shiina H, Igawa M, Breault J, Ribeiro-Filho L, Pookot D, Urakami S, Terashima M, Deguchi M, Yamanaka M, Shirai M, et al. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Clin Cancer Res 2003, 9:2121-2132.
38. Hatsell S, Rowlands T, Hiremath M, Cowin P. Beta-catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia 2003, 8:145-158. 10.1023/A:1025944723047, 14635791.
39. Rowlands TM, Pechenkina IV, Hatsell S, Cowin P. Beta-catenin and cyclin D1: connecting development to breast cancer. Cell Cycle 2004, 3:145-148. 10.4161/cc.3.2.665, 14712077.
40. Yang SZ, Kohno N, Yokoyama A, Kondo K, Hamada H, Hiwada K. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines. Int J Oncol 2001, 18:541-548.
41. Tang W, Dodge M, Gundapaneni D, Michnoff C, Roth M, Lum L. A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. Proc Natl Acad Sci USA 2008, 105:9697-9702. 10.1073/pnas.0804709105, 2453074, 18621708.
42. van Noort M, Clevers H. TCF transcription factors, mediators of Wnt-signaling in development and cancer. Dev Biol 2002, 244:1-8. 10.1006/dbio.2001.0566, 11900454.
43. Ziegler S, Rohrs S, Tickenbrock L, Moroy T, Klein-Hitpass L, Vetter IR, Muller O. Novel target genes of the Wnt pathway and statistical insights into Wnt target promoter regulation. FEBS J 2005, 272:1600-1615. 10.1111/j.1742-4658.2005.04581.x, 15794748.
44. Parrinello S, Lin CQ, Murata K, Itahana Y, Singh J, Krtolica A, Campisi J, Desprez PY. Id-1, ITF-2, and Id-2 comprise a network of helix-loop-helix proteins that regulate mammary epithelial cell proliferation, differentiation, and apoptosis. J Biol Chem 2001, 276:39213-39219. 10.1074/jbc.M104473200, 11498533.
45. Zhai Y, Wu R, Schwartz DR, Darrah D, Reed H, Kolligs FT, Nieman MT, Fearon ER, Cho KR. Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas. Am J Pathol 2002, 160:1229-1238. 10.1016/S0002-9440(10)62550-3, 1867221, 11943708.
46. Sankpal NV, Willman MW, Fleming TP, Layfield JD, Gillanders WE. Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion. Cancer Res 2009, 69:753-757. 10.1158/0008-5472.CAN-08-2708, 19141643.